Board Of Directors

Mr Lim See Wah

Chairman, Executive Director & CEO

Mr Lim See Wah was appointed to the Board as Executive Director on 12 December 2017.

The founder of the Group, Mr Lim See Wah holds a remarkable track record of over 30 years of experience in the pharmaceutical industry and is responsible for overseeing our overall operations and managing our strategic direction.

See Wah graduated with a Bachelor of Science (Pharmacy) with Honours from National University of Singapore in 1992. He also obtained a Graduate Diploma in Business Administration from Singapore Institute of Management in 1994.

Read More

Dr Tan Kia King

Non-Executive Director

Dr Tan Kia King was appointed to the board as Non- Executive Director on 12 December 2017.

With a distinguished career spanning over 30 years as a medical doctor, he commenced his journey as a Medical Officer in the Ministry of Health. Having served as the Managing Director of Westpoint Family Hospital Pte. Ltd., Kia King was entrusted with overseeing the day-to-day operations of the hospital. 

He served as Chairman of the Sengkang West Citizen Consultative Committee in 2022 and Grassroot Advisor to the Sengkang North Grassroots Organisation in 2023. He was awarded National Day Awards; the Public Service Medal (Pingat Bakti Masyarakat) in 2016 and Public Service Star (Bintang Bakti Masyarakat) in 2021.

Kia King graduated from the National University of Singapore with a Bachelor of Medicine and Bachelor of Surgery in 1993. With his depth of experience in the medical field, Kia King continues to enrich our strategic initiatives.

Read More

Mr Heng Wee Koon

Lead Independent Director

Mr Heng Wee Koon was appointed to the Board as Lead Independent Director on 23 April 2018.

Currently serving as a Senior Advisor to Nihon M&A Center Singapore Pte. Ltd., a mergers and acquisitions advisory firm, he also provides guidance as an advisor to Regional Marine & Engineering Services Pte. Ltd., an offshore marine engineering company. Wee Koon’s journey includes a significant tenure with KPMG, where he joined the Transaction Services department in January 2007, achieving the position of Executive Director in October 2008. He later became a Partner at KPMG Advisory LLP, departing in December 2016.

He graduated with Honours in Bachelor of Business Administration from the National University of Singapore in 1994. Furthering his academic achievements, Wee Koon obtained a Master of Business Administration from Nanjing University, China, in 1997. A member of the CFA (Chartered Financial Analyst) Society Singapore, Wee Koon’s wealth of experience and expertise elevates our growth and standards of governance.

Read More

Mr Ng Eng Leng

Independent Director

Mr Ng Eng Leng was appointed to our Board as Independent Director on 23 April 2018. 

He has been a Senior Partner at Dentons Rodyk & Davidson LLP since October 2011, specialising in mergers and acquisitions and corporate matters with over 33 years of legal practice experience.

He earned his Bachelor of Laws (LLB) from the National University of Singapore in 1989 and later obtained a Master of Laws (LLM) from the same institution in 1995. Eng Leng’s legal acumen makes him a valuable member of the Board.

Read More

Ms Tan Seok Hoong @ Mrs Audrey Liow

Independent Director

Ms Tan Seok Hoong @ Mrs Audrey Liow was appointed to the Board as Independent Director on 29 July 2019. Audrey brings a valuable perspective with her multifaceted, robust background in consumer marketing, general management, research and development, and operations within the food, nutrition, health, and wellness industry. 

After 30 years of dedicated service with Nestlé Group, she retired in May 2018 as the Market Head, Chairman, and CEO of Nestlé Indochina Region. Throughout her illustrious tenure at Nestlé, Audrey held various commercial and leadership roles in Singapore, China, Switzerland, and Southeast Asia.

Audrey previously served as a Director on the Board of Nestlé ROH (Thailand) Ltd and on the Tanjong Katong Girls’ School Advisory Committee. She is currently an Independent Director at Venture Corporation Limited and Heliconia Capital Management Pte Ltd. 

Audrey is an alumna of the National University of Singapore (NUS), holding a Bachelor of Science degree. In 2014, she received the Outstanding Science Alumni Award from NUS in recognition of her outstanding achievements and contributions. She has also completed the Leadership Program at London Business School and the Berkeley-Nanyang Advanced Management Program at Nanyang Technological University. Successfully blending academic success with career expertise, Audrey continues to contribute to Hyphens’ growth and transformation.

Read More

Mr Chan Kiat

Independent Director

Mr Chan Kiat was appointed to the Board as Independent Director on 5 November 2020. 

Currently, he serves as a Managing Director and Partner of Archipelago Capital Partners, a Singapore-based private equity fund manager focused on Southeast Asia, a position he has held since 2016.

Before co-founding Archipelago Capital Partners, Kiat held the position of Executive Vice President of Investments at Singapore Post Limited. Prior to that, he had been with McKinsey & Company and was a member of the Corporate Finance Practice in Southeast Asia. He graduated from the National University of Singapore with a Bachelor of Engineering in 1996 and obtained a Master of Business Administration from INSEAD in 2000.

With over 20 years of experience in corporate finance, strategy and investments, Kiat is a valuable addition to the Board with his depth of insight and exposure.

Read More